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Abstract 
Background: Asthma is an increasing global health problem, and novel strategies to prevent or ameliorate the con‑
dition are needed. Here, the effects of 80 % ethanol extracts of Salvia plebeia R. Br. (SE) on an induced inflammatory 
response were investigated.
Results: Salvia plebeia R. Br. inhibited production of pro‑inflammatory cytokines, such as TNF‑α and IL‑6, as well as 
nitric oxide (NO) in LPS‑stimulated RAW 264.7 cells. NO and pro‑inflammatory cytokine production was suppressed 
more effectively by SE of the aerial parts (SE‑A) than of the roots (SE‑R) of S. plebeia. In BEAS‑2B cells, both SE‑A and 
SE‑R inhibited the increase in production of the inflammatory cytokines IL‑6 and IL‑8. We also investigated the anti‑
asthmatic effects of SE in an ovalbumin (OVA)‑induced BALB/c mouse model. SE‑A treatment significantly reduced 
the number of airway eosinophils, IL‑4 and IL‑13 levels, mucus production, and inflammatory infiltration, as compared 
with the corresponding levels in the untreated, OVA‑induced mice, and had similar effects to dexamethasone.
Conclusions: Salvia plebeia ethanol extract ameliorated the induced inflammatory response in RAW 264.7 and BEAS‑
2B cells, with more effective inhibition noted for SE‑A than for SE‑R. SE‑A treatment was effective in improving the 
histopathological changes in the lungs of asthma model mice via modulation of eosinophils and Th2 cytokines. These 
results suggest that SE‑A can be considered as a therapeutic agent that can potentially relieve asthma.
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Background
Asthma is a chronic inflammatory disease character-
ized by the presence of inflammatory cells in the air-
way, which can be elicited by a variety of environmental 
allergens, such as air pollutants and tobacco smoke [1]. 
Common symptoms in asthma include coughing (espe-
cially at night), wheezing, shortness of breath, and chest 
tightness or pain. These symptoms are caused by chroni-
cally hyperactive (contraction of the muscles surround-
ing the airways) and inflamed airways, which leads to 
airflow obstruction [2]. Asthma is a major health prob-
lem affecting people worldwide; the prevalence of asthma 
is continually increasing, with substantial associated 
healthcare expenditures [3, 4]. It is urgent to gain full 
understanding of the mechanism underlying the develop-
ment of asthma and to develop preventative and/or ame-
liorating strategies.
Several drugs are currently available for asthma ther-
apy. Corticosteroids, the most potent nonspecific anti-
inflammatory agents, are widely used for improvement of 
lung function in patients with asthma. However, it is well 
known that inhaled corticosteroids are limited in their 
capacity to modify airway remodelling [5]. Therefore, 
there has been increasing interest in the development of 
natural drugs with fewer side effects than the currently 
used agents [6]. Recent studies have indicated that herbal 
medicines can improve symptoms of asthma, by provid-
ing experimental evidence of the inhibition of ovalbumin 
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(OVA)-induced asthma in mouse models of this condi-
tion [7, 8].
Salvia plebeia R. Br is a biannual grass that is distrib-
uted widely across many countries. S. plebeia has been 
shown to have anti-oxidant and anti-inflammatory effects 
[9]. It has been reported that the compound homoplan-
taginin isolated from the above-ground parts of S. plebeia 
has a protective effect on oxidative stress-induced hepat-
ocyte injury and inflammatory liver injury [10]. Although 
S. plebeia is traditionally used to treat inflammatory dis-
eases, such as colds, coughs, and mild asthma, the anti-
inflammatory and anti-asthma effects of S. plebeia have 
not been reported in detail. In addition, there have been 
few reports of the anti-inflammatory effects of the differ-
ent parts of S. plebeia.
This study aimed to investigate the anti-inflammatory 
effects of S. plebeia in  vitro and in a mouse model of 
asthma, the OVA-induced mouse model. We hypoth-
esized that S. plebeia would show anti-inflammatory 
effects both in  vitro and in  vivo and that the activity of 
the aerial parts and the roots would differ.
Results
Effect of S. plebeia ethanol extract 
on lipopolysaccharide‑induced inflammatory responses 
in RAW264.7 Cells
To investigate the anti-inflammatory effect of S. ple-
beia (SE), SE was treated on lipopolysaccharide-
induced inflammatory responses in RAW 264.7 cells. A 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay showed that the 80  % ethanol 
extract ofSE had no significant effect on RAW 264.7 cell 
viability at a concentration of 1000 μg/mL. Treatment of 
RAW 264.7 macrophages with LPS (200 ng/mL) caused 
a significant increase in NO, TNF-α, and IL-6 produc-
tion. However, both the extract of the aerial parts (SE-A) 
and of the roots (SE-R) of S. plebeia markedly inhibited 
the LPS-induced production of NO, TNF-α, and IL-6, 
in a dose-dependent manner. In particular, NO and pro-
inflammatory cytokine production was suppressed more 
effectively by SE-A than by SE-R (Fig. 1).
To identify inflammatory genes modulated by SE, we 
compared the gene expression profiles of LPS-stimu-
lated RAW 264.7 and LPS-stimulated RAW 264.7 cells 
treated with SE-A or SE-R using the Mouse Inflamma-
tory Response & Autoimmunity RT2 Profiler PCR array 
(SABiosciences, Frederick, MD, USA). Quantitative RT-
PCR array experiments showed that expression of most 
genes in LPS-stimulated RAW 264.7 cells remained 
unchanged, by at least a fourfold margin, after treatment 
with either of the SE (Fig.  2). However, SE-A treatment 
modulated three genes associated with inflammatory 
signalling in RAW 264.7 cells. Expression of the genes 
encoding chemokine (C–C motif ) ligand 22 (Ccl22) and 
interleukin 1 beta (Il1b) was markedly reduced in SE-A-
treated RAW 264.7 cells. Although not statistically sig-
nificant, the selectin, endothelial cell (SELE) protein, was 
increased sixfold by SE-A treatment as compared with 
untreated, LPS-stimulated RAW 264.7 cells (P = 0.10).
Effect of SE on TNF‑α/LPS‑induced inflammatory responses 
in BEAS‑2B cells
We treated BEAS-2B human bronchial epithelial cells 
with TNF-α (10  ng/mL) or LPS (200  ng/mL) to stimu-
late inflammatory mediator production and assessed the 
effect of SE. SE had no significant effect on BEAS-2B cell 
viability up to a dose of 1000  μg/mL (data not shown). 
In LPS-stimulated BEAS-2B, both SE-A and SE-R effec-
tively prevented the increase in IL-6 and IL-8 production, 
as compared to treatment with LPS alone (Fig.  3). The 
production of IL-6 was significantly increased by TNF-α 
and significantly inhibited by SE-A and SE-R in a dose-
dependent manner.
Effect of SE‑A on inflammatory cell numbers in mouse 
bronchoalveolar lavage fluid (BALF)
Eighteen hours after the final intranasal OVA or PBS 
challenge, BALF from the lungs was collected to deter-
mine the levels of recruited inflammatory cells. As shown 
in Fig. 4, the numbers of total cells in the BALF obtained 
from the OVA-challenged group were significantly higher 
than those of CON group. OVA challenge increased 
inflammatory cells, such as neutrophils, eosinophils, lym-
phocytes, and macrophages. On the other hand, SE-A 
treatment significantly decreased the total number of 
cells, and the numbers of neutrophils and eosinophils, in 
BALF as compared with the PLA group.
Effect of SE on inflammatory cell infiltration and mucus 
production in lung tissue
To investigate the inhibitory effect of SE-A treatment 
on inflammatory infiltration and mucus production, we 
analyzed the histology of lung tissue using hematoxylin 
and eosin (H&E) and periodic acid-Schiff (PAS) stain-
ing, respectively. The number of infiltrated cells was 
increased in the lungs of the PLA group, as compared 
with the CON group, as characterized by observation of 
an intense inflammatory infiltrate. On the other hand, 
inflammation was alleviated by SE-A treatment, as indi-
cated by the reduced surface area of inflammatory infil-
tration observed in lungs from mice in the SE-A group 
(Fig. 5).
Mucus overproduction was observed in the bron-
chial airway of the PLA group compared with the CON 


























































































































































Fig. 1 Effect of SE on a cell viability, b NO production, c TNF‑α production and d IL‑6 production in LPS‑treated RAW 264.7 macrophages. Values are 
presented as mean ± SE (n = 3). Means with the same letters are not significantly different at P < 0.05 using Duncan’s multiple‑range test
Fig. 2 Focused quantitative RT‑PCR analysis of inflammatory responses in RAW 264.7 cells exposed to SE‑A or SE‑R. Both SE‑A and SE‑R were used at 
concentrations of 1000 μg/mL. Lines above and below the centre regression lines indicate fourfold changes in gene expression (three replicates)
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group. The score of mucus production in the SE-A group 
showed a trend towards reduction, as compared to the 
PLA group, which approached, but did not attain, statis-
tical significance (Fig. 6).
Effect of SE on cytokine levels in BALF
The levels of Th2 cell-derived cytokines, such as IL-4, 
IL-5, and IL-13 were examined in the BALF of OVA-
stimulated BALB/c mice. Th2 cytokine levels in the 
BALF of OVA-stimulated BALB/c mice were significantly 
higher than those in the PBS-stimulated group. However, 
the SE-A-treated group showed significantly reduced 
IL-4, IL-5, and IL-13 levels (Fig. 7).
Discussion
The present study investigated the anti-inflammatory 
effects of S. plebeia both in  vitro and in  vivo. Both the 
extract of the aerial parts (SE-A) and of the roots (SE-R) 
of S. plebeia markedly inhibited the LPS-induced pro-
duction of NO, TNF-α, and IL-6, in a dose-dependent 
manner. Jung et al. [9] showed that the ethanol extract of 
the whole plant of S. plebeia significantly decreased the 
levels of NO and iNOS in LPS-stimulated RAW 264.7 
cells. However, we used extracts of the aerial and root 
parts of S. plebeia separately, and found that the aerial 
parts were more effective in ameliorating allergic inflam-
matory responses.
In quantitative RT-PCR array experiments, LPS-stim-































































































































Fig. 3 Effect of SE on a IL‑6 production and b IL‑8 production in LPS‑treated BEAS‑2B cells and on c IL‑6 production and d IL6 mRNA levels in 
TNF‑α‑treated BEAS‑2B cells. Values are presented as mean ± SE (n = 3). Means with the same letters are not significantly different at P < 0.05 using 
Duncan’s multiple‑range test
Fig. 4 Effects of SE on the recruitment of inflammatory cell numbers 
in the BALF of mice. Cells were isolated by centrifugation and stained 
with Diff‑Quik staining reagent. Cell numbers were determined under 
a light microscope. Values are expressed as mean ± SE (n = 8). Means 
with the same letters are not significantly different at P < 0.05 using 
Duncan’s multiple‑range test
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three genes associated with inflammatory signalling in 
RAW 264.7 cells, by at least a fourfold margin. Interest-
ingly, the gene encoding chemokine (C–C motif ) ligand 
22 (Ccl22), which induces the selective migration of Th2 
cells, but not of Th1 cells, by triggering CCR4 [11], was 
markedly reduced in SE-A-treated RAW 264.7 cells. 
The gene encoding interleukin 1 beta (Il1b) was also 
reduced sixfold by SE-A treatment in LPS-stimulated 
RAW 264.7 cells. Il1b has been known as a pro-inflam-
matory cytokine that has been implicated in driving the 
inflammatory process in various disease states, includ-
ing asthma [12]. Although not statistically significant, 
the selectin, endothelial cell (SELE) protein, which has 
been noted to play important roles in the production of 
allergic inflammation [13], was increased sixfold by SE-A 
treatment as compared with untreated, LPS-stimulated 
RAW 264.7 cells. These data indicated that SE-A showed 
improved inflammatory responses through modulation 
of the expression of the relevant genes.
Next, we investigated the anti-inflammatory effect 
of both SE-A and SE-R in stimulated BEAS-2B human 
bronchial epithelial cells. BEAS-2B was treated with 
TNF-α or LPS to stimulate inflammatory mediators. 
Upon stimulation with LPS, TNF-α, or IL-4, BEAS-2B 
cells are reported to secrete pathologically elevated lev-
els of cytokines and chemokines, including IL-6, IL-8, 
eotaxin, and RANTES [14, 15]. Our data showed that 
SE-A and SE-R had an inhibitory effect on the produc-
tion of cytokines, including IL-6 and IL-8, in stimulated 
cells, with SE-A showing more effective inhibition. In 
addition, in a real-time PCR assay, SE-A also effectively 
decreased the levels of IL6 mRNA in TNF-α-stimulated 
BEAS-2B cells compare to SE-R.
This in vitro study showed that SE-A and SE-R had an 
inhibitory effect on inflammatory responses in stimu-
lated cells, with SE-A showing more effective inhibition. 
Inflammation related genes was regulated more effec-




























Fig. 5 Effects of SE on the recruitment of inflammatory cells in mouse lung tissue. a Histological examination of lung tissue was performed 24 h 
after the last OVA challenge. Lung tissues were fixed, sectioned at 4‑µm thickness, and stained with H&E solution. b Scoring of the extent of inflam‑
mation by quantitative analysis of inflammatory cell infiltration in lung sections. Values are expressed as mean ± SE (n = 8). Means with the same 
letters are not significantly different at P < 0.05 using Duncan’s multiple‑range test
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anti-inflammatory effects of SE-A in vivo to confirm the 
physiological relevance of our in vitro findings.
In vivo study was performed using OVA-induced 
asthma model mice. The major feature of asthma is air-
way inflammation, which predominantly involves eosino-
phils, macrophages, and mast cells [16]. Important cell 
types in airway inflammation are eosinophils and leu-
kocytes, which are not only present in the airway wall, 
but are also present in large numbers in the sputum and 
BALF [17]. To assess inflammatory cell numbers, BALF 
was collected from the lungs of OVA-stimulated BALB/c 
mice. The numbers of total cells, neutrophils, eosino-
phils, lymphocytes, and macrophages in BALF were 
significantly increased in the placebo (PLA) group com-
pared with the control (CON) group. SE-A treatment 
significantly decreased the total number of cells, and 
the numbers of neutrophils and eosinophils, in BALF as 
compared with the PLA group. SE-A mainly decreased 
the numbers of eosinophils, which reflect asthmatic 
activity and the severity of asthma [18, 19]. However, the 
numbers of lymphocytes and macrophages did not signif-
icantly decrease with SE-A treatment. These effects were 
similar between the SE-A and dexamethasone (DEX) 
groups. These results were confirmed by histological 
analysis, which showed that SE inhibited inflammatory 
cell infiltration and mucus hypersecretion.
To investigate the inhibitory effect of SE-A treatment 
on inflammatory infiltration and mucus production, we 
analyzed the histology of lung tissue using H&E and PAS 
staining, respectively. The number of infiltrated cells was 
increased in the lungs of the PLA group, as characterized 
by an intense inflammatory infiltrate, as compared with 
the CON group. On the other hand, inflammation was 
alleviated by SE-A treatment, as indicated by the reduced 
surface area of inflammatory infiltration observed in 
lungs from mice in the SE-A group.
Mucus overproduction was observed in the bronchial 
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Fig. 6 Effects of SE on mucus production in lung tissue. a Histological examination of mucus secretion in lung tissue was performed 24 h after the 
last OVA challenge. Lung tissues were fixed, sectioned at 4‑µm thickness, and stained with periodic acid Schiff (PAS) reagent to assess mucus pro‑
duction (magnification ×100 and 200). b Scoring of mucus was quantified according to the percentage of PAS‑positivity among all epithelial cells. 
Values are expressed as mean ± SE (n = 8). Means with the same letters are not significantly different at P < 0.05 using Duncan’s multiple‑range test
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The mucus production in the SE-A group tended to be 
reduced as compared to the PLA group. Histopathologi-
cal alterations, such as goblet cell hyperplasia, mucus 
hypersecretion, and infiltration of inflammatory cells in 
lung tissue, are observed in asthmatic conditions [20]. 
IL-4 and IL-13 play critical roles in IgE switching within 
B cells, which triggers mucus hypersecretion and goblet 
cell hyperplasia, whereas IL-5 is essential for the activa-
tion and survival of eosinophils, as well as in the devel-
opment of airway hyper responsiveness [21]. Similar 
alterations, including histopathological changes, were 
seen in the lung tissue of OVA-induced mice. However, 
the extent of these alterations was significantly decreased 
in SE-A-treated mice, similar to that observed in DEX-
treated mice, which were used as the positive control. 
These data were in agreement with the results obtained 
for Th2 cytokines in BALF. Based on these findings, we 
propose that SE-A attenuates the inflammatory response 
in OVA-induced allergic asthma via modulation of eosin-
ophils and Th2 cytokines.
The levels of Th2 cell-derived cytokines, such as IL-4, 
IL-5, and IL-13 were examined in the BALF of OVA-
stimulated BALB/c mice. Th2 cytokine levels in the PLA 
group were significantly higher than those in the CON 
group. However, the SE-A-treated group showed sig-
nificantly reduced IL-4, IL-5, and IL-13 levels. IL-4 and 
IL-13 can be produced by a variety of cell types of the 
innate immune system, which plays a crucial role dur-
ing asthma [1]. IL-13 induces the pathophysiological 
features of asthma in a manner that is independent of 
IgE and eosinophils [22]. Infiltration of eosinophils into 
the airways is linked to the production of IL-5, which is 
important for eosinophil proliferation, activation, and 
migration [23]. Our data show that SE inhibits the pul-
monary accumulation of eosinophils, in parallel with a 
decrease in the IL-5 level in BALF. These results suggest 
that SE-A plays a key role in blocking mucus secretion 
and recruitment of eosinophils in the lungs, partially 



























































































Fig. 7 Effects of SE‑A on cytokine levels in BALF. BALF was collected 24 h after the final OVA challenge in mice. Each sample was analyzed using 
ELISAs. a IL‑4, b IL‑5 and c IL‑13. Values are expressed as mean ± SE (n = 8). Means with the same letters are not significantly different at P < 0.05 
using Duncan’s multiple‑range test
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Several studies have shown that the aerial parts of S. 
plebeia are rich in flavonoids, such as luteolin, nepitrin, 
quercetin, rosmarinic, and homoplantaginin [24, 25]. 
Jin et  al. reported that luteolin-7-O-glucoside isolated 
from the leaves and branches of Ailanthus altissima has 
an anti-asthmatic effect through the downregulation of 
Th2 cell-derived cytokine expression in an OVA-induced 
asthma model [26]. The compound homoplantaginin, 
which is the main flavonoid from S. plebeia,is known to 
have inhibitory effects on inflammation [27]. He et  al. 
reported that homoplantaginin ameliorated palmitic 
acid-induced endothelial inflammation by suppressing 
toll-like receptor-4 and NLRP3 pathways, and restoring 
nitric oxide generation [28]. It is expected that the posi-
tive effects of SE treatment can likely be attributed to the 
flavonoids, such as luteolin and homoplantaginin, within 
SE.
Conclusions
In conclusion, the ethanol extract of S. plebeia amelio-
rated the inflammatory response stimulated by LPS and/
or TNF-α in RAW 264.7 and BEAS-2B cells, with more 
effective inhibition noted for SE-A than for SE-R. SE-A 
treatment was effective in improving histopathological 
changes in the lungs in asthma model mice via modula-
tion of eosinophils and Th2 cytokines. Further studies are 
required to determine the specific mechanisms of action 
of this extract of S. plebeia.
Methods
In vitro studies
Plant material and extract preparation
The aerial parts and roots of S. plebeia were purchased 
from material harvested from a natural population on a 
farm in the Paju area of the Gyeonggi-do (South Korea).
After a multiple-step cleaning process and drying, 
300  g of the different parts of S. plebeia was extracted 
twice with 10 volumes of 80  % ethanol at room tem-
perature for 16 and 3 h, respectively. The extracts of the 
different parts of S. plebeia were filtered through No. 6 
filter paper (Advantec Co., Tokyo, Japan) and were con-
centrated until dry by sequential use of a rotary evapora-
tor (EYELA N-1000, Riakikai Co., Ltd., Tokyo, Japan) at 
30 °C. Then, each of the 80 % ethanol filtrates were frozen 
and lyophilized (PVTFD 10R, Ilsin Lab, Yangju, Korea). 
The final lyophilized extracts were stored at −70 °C until 
required for experimental use.
Cells and culture
Murine macrophage RAW264.7 cells (Korean Cell Line 
Bank, Seoul, Korea) and human bronchial epithelial 
BEAS-2B cells (ATCC, Manassas, VA, USA) were used 
for in  vitro experiments. These cells were cultured in 
DMEM (Gibco, Rockville, IL, USA) supplemented with 
10 % heat-inactivated fetal bovine serum (Gibco, Rock-
ville, IL, USA) and penicillin–streptomycin solution 
(100  units/mL penicillin and 100  μg/mL streptomycin; 
HyClone Laboratories Inc., South Logan, UT, USA). 
BEAS-2B cells were cultured in BEGE medium with a 
Bullet Kit (Lonza, Walkersville, MD, USA). All cells 
were grown in a 5  % CO2-humidified atmosphere at 
37 °C.
Preparation of LPS and TNF‑α solution
Lipopolysaccharide (LPS) was dissolved in phosphate-
buffered saline at 1  mg/mL and stored at −20  °C. This 
solution was filtered through a 0.22-μm membrane 
before use. A fresh stock solution of TNF-α (200  μg/
mL) was prepared in phosphate-buffered saline and was 
added directly to cell culture medium. LPS and TNF-α 
were treated at a final concentration of 200 and 10 ng/mL 
individually to stimulate cell cultures [29].
Cell cytotoxicity assay
Cell cytotoxicity was assessed using the MTT assay. 
After the incubation period, cells were added to 100 μL 
of 5  mg/mL thiazolyl blue tetrazolium bromide (Sigma, 
St. Louis, MO) solution/well and were incubated further 
for 4 h in a humidified atmosphere (37  °C in 5 % CO2). 
The medium was replaced with 1 mL dimethyl sulfoxide 
(DMSO). The absorbance was measured at 540 nm in a 
microplate reader (Molecular Devices Inc., Sunnyvale, 
CA). Cell cytotoxicity was expressed as percentage values 
compared with the negative, phosphate-buffered saline 
(PBS) control, which was considered to represent 100 % 
cell viability.
Nitric oxide measurement
The anti-inflammatory properties of the aerial parts and 
roots from S. plebeia were determined in LPS-stimulated 
RAW264.7 cells. RAW264.7 cells were incubated with 
200 ng/mL of LPS in the presence of ethanol extracts of 
the aerial parts or roots of S. plebeia (100–1000 μg/mL) 
for 24  h. Briefly, equal volumes of incubation medium 
supernatant and Griess reagent were allowed to react for 
15 min, and the nitrite content was measured by deter-
mining absorbance of the mixture at 540 nm. The nitrite 
concentration in the sample was calculated using a stand-
ard curve prepared with NaNO2.
Measurement of inflammatory cytokine levels
TNF-α, IL-6, and IL-8 cytokine levels in the RAW264.7 
and BEAS-2B cell culture media were measured using an 
enzyme-linked immunosorbent assay (ELISA), accord-
ing to the manufacturer’s protocols (BD Biosciences. San 
Diego, CA, USA).
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Real‑time quantitative reverse transcription‑PCR
Total RNA was isolated from RAW264.7 or BEAS-
2B cells using the RNeasy Mini Kit (Qiagen, Valencia, 
CA, USA), and RNA integrity (RIN  >  9.0) was assessed 
using a Bioanalyzer 2100 (Agilent Technologies, Santa 
Clara, CA, USA). The Mouse Inflammatory Response 
& Autoimmunity PCR array (SABiosciences, Frederick, 
MD, USA) were used to profile the genes differentially 
expressed in RAW 264.7 cells, according to the manufac-
turer’s instructions. The complete list of genes assayed 
on the array is provided on the manufacturer’s website 
(http://www.sabiosciences.com/PCRArrayPlate.php). 
For each plate, 0.5 µg of RNA was converted to double-
stranded cDNA using the RT2 first strand synthesis kit 
(Qiagen, Valencia, CA, USA). After mixing this with the 
SABiosciences RT2 qPCR master mix, the cDNA was 
pipetted into the 96-well profile plate and amplified on 
CFX96TM real-time pcr detection system (BIO-RAD). 
Data were normalized using β-actin as an endogenous 
control and fold-changes in expression were calculated 
using SABiosciences online software (http://pcrdata-
analysis.sabiosciences.com/pcr/arrayanalysis.php). To 
observe the maximum differential expression, both SE-A 
and SE-R were used at concentrations of 1000  μg/mL. 
For Il6, expression was detected by using the CFX96 
real time system (Bio-Rad) with β-actin as control. 
The primer sequences are as follows, β-actin forward: 
5′-GTGGGGCGCCCCAGGCACCA-3′, β-actin reverse: 
5′-CTCCTTAATGTCACGCACGATTTC-3′, IL6 for-




The experimental design was approved by the Institu-
tional Animal Care and Use Committee (IACUC) of the 
National Academy of Agricultural Science (reference 
number: NAAS-1307).
Six-week-old female BALB/c mice (15–19 g) were pur-
chased from Central Lab. Animal Inc. (Seoul, Korea). 
Mice were housed in Plexiglas cages and maintained in 
an air-conditioned room at 23 ± 3 °C under an automatic 
lighting schedule (12-h light/dark cycle). The mice were 
allowed free access to water and a laboratory diet (Purina 
Inc., St Louis, MO, USA) for the experimental period.
Sensitization and inhalational exposure
A schematic presentation of sensitization and inhalation 
exposure is shown in Fig. 8. Thirty-two mice were divided 
into four groups; groups I (control [CON]), II (placebo 
[PLA]), III (dexamethasone 3 mg kg−1 day−1 [DEX]), and 
IV (SE-A 100 mg kg−1 day−1), with each group including 
eight mice. Mice in Groups II, III, and IV were sensitized 
with an intraperitoneal (i.p.) injection of 20  µg of OVA 
emulsified in 2  mg aluminium hydroxide in a total vol-
ume of 200 µL in PBS per animal on days 0 and 14. The 
challenge was administered by inhalation of nebulized 
3 % OVA for 30 min on days 21, 22, and 23. Oral treat-
ment, consisting of 3  mg/kg of dexamethasone (group 
III), or 100 mg/kg of SE-A (group IV), was administered 
daily from day 17 to day 23 of the protocol. CON and 
PLA mice were orally treated with PBS. Mice in the con-
trol group (group I) received PBS without OVA on days 0 
and 14 and aerosolized saline without alum for 30 min on 
days 21, 22, and 23.
Collection of bronchoalveolar lavage fluid and lung samples
On the day after the last challenge, mice were euthanized 
with a solution of Zoletil (250  mg/5  cc, Virbac, Carros, 
France) and Rumpun (2 %, Bayer, Leverkusen, Germany). 
Bronchoalveolar lavage (BAL) was performed four times 
by intratracheal instillation of 250 µL of phosphate-buff-
ered saline. The BAL fluid (BALF) was centrifuged, and 
the supernatants were used for cytokine measurements. 
Cell pellets were resuspended in 1 mL of PBS and used 
for total and differential cell counts. The total cell number 
in BALF samples was counted using a hemocytometer. 
Numbers of infiltrated inflammatory cells, stained with 
Diff-Quick, were quantified by microscopy.
Histopathological analysis
After BALF was obtained, lungs of the mice were 
removed by dissection and fixed in 10  % formalin, and 
then embedded in paraffin. Sections were cut at 4-µm 
thickness and stained with hematoxylin and eosin (H&E) 
for the evaluation of inflammatory cell infiltration, or 
with periodic acid-Schiff (PAS) for the identification of 
goblet cells. The slides were examined by a treatment-
blinded pathologist. The inflammatory score was graded 
on the following scale: 0, none; 1, minimal; 2, mild; 3, 
moderate; 4, severe. Hyperplasia of the goblet cells was 
quantified according to the percentage of PAS-positivity 
among all epithelial cells: 0, none; 1, <25 %; 2, 25–50 %; 3, 
50–75 %; 4, >75 % [23]. Scoring of inflammatory cells and 
goblet cells was performed in at least 3 different fields for 
each lung section.
Measurement of inflammatory cytokine levels
IL-4, IL-5, and IL-13 levels in BALF were determined by 
ELISA according to the manufacturer’s protocols (R&D 
system, Minneapolis, MN, USA).
Statistical analysis
Data were expressed as mean  ±  SE (or SD) for each 
group. All statistical analyses were performed with SAS 
9.2 (SAS Institute; Cary, NY, USA). Results were analyzed 
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by one-way analysis of variance. When a significant dif-
ference was indicated, a Duncan’s multiple-range test was 
performed to determine significant differences among 
the groups. A P value <0.05 was considered statistically 
significant.
Abbreviations
LPS: lipopolysaccharide; NO: nitric oxide; OVA: ovalbumin; PAS: periodic 
acid‑Schiff; PBS: phosphate buffered saline; PCR: polymerase chain reaction; 
qPCR: quantitative real time polymerase chain reaction; RNA: ribonucleic acid; 
RT‑PCR: real time reverse transcription polymerase chain reaction; Th1: type 1 
helper T cell; Th2: type 2 helper T cell; TNF‑α: tumournecrosis factor‑α.
Authors’ contributions
HHJ performed the experiments, analyzed the data, and wrote the manu‑
script; SYC and MJK conducted the animal experiments and analyzed the 
data; JBK, SHL, and MYL participated in data interpretation and reviewed the 
manuscript; YML contributed to study design and manuscript writing. All 
authors read and approved the final manuscript.
Author details
1 Functional Food & Nutrition Division, National Institute of Agricultural Sci‑
ence, Rural Development Administration (RDA), Wanju 565‑851, South Korea. 
2 Herbal Medicine EBM Research Center, Korea Institute of Oriental Medicine, 
Daejeon 305‑811, South Korea. 3 Department of Food and Nutrition, Seoul 
Women’s University, Seoul 139‑774, South Korea. 
Acknowledgements
This study was supported by research project of National Institute of Agricul‑
tural Science of Rural Development Administration, Republic of Korea (Project 
No. PJ01178701).
Competing interests
The authors declare that they have no competing interests.
Received: 9 November 2015   Accepted: 27 September 2016
References
 1. Oeser K, Maxeiner J, Symowski C, Stassen M, Voehringer D. T cells are the 
critical source of IL‑4/IL‑13 in a mouse model of allergic asthma. Allergy. 
2015;70(11):1440–9.
 2. Centers for Disease Control and Prevention. Asthma facts—CDC’s national 
asthma control program grantees. Atlanta, GA: U.S. Department of Health 
and Human Services, Centers for Disease Control and Prevention. 2013.
 3. Baïz N, Annesi‑Maesano I. Is the asthma epidemic still ascending? Clin 
Chest Med. 2012;33(3):419–29.
 4. Bahadori K, Doyle‑Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, 
et al. Economic burden of asthma: a systematic review. BMC Pulm Med. 
2009;9(1):1.
 5. Durrani SR, Viswanathan RK, Busse WW. What effect does asthma treat‑
ment have on airway remodeling? Current perspectives. J Allergy Clin 
Immunol. 2011;128(3):439–48.
 6. Hocaoglu AB, Karaman O, Erge DO, Erbil G, Yilmaz O, Kivcak B, et al. Effect 
of hedera helix on lung histopathology in chronic asthma. Iran J Allergy, 
Asthma Immunol. 2012;11(4):316–23.
 7. Shin IS, Lee MY, Lim HS, Ha H, Seo CS, Kim JC, et al. An extract of Cratae‑
gus pinnatifida fruit attenuates airway inflammation by modulation of 
matrix metalloproteinase‑9 in ovalbumin induced asthma. PLoS ONE. 
2012;7(9):e45734. doi:10.1371/journal.pone.0045734.
 8. Lee MY, Seo CS, Lee JA, Lee NH, Kim JH, Ha H, et al. Anti‑asthmatic effects 
of Angelica dahurica against ovalbumin‑induced airway inflammation via 
upregulation of heme oxygenase‑1. Food Chem Toxicol. 2011;49(4):829–
37. doi:10.1016/j.fct.2010.12.004.
 9. Jung H‑J, Song YS, Lim C‑J, Park E‑H. Anti‑inflammatory, anti‑angiogenic 
and anti‑nociceptive activities of an ethanol extract of Salvia plebeia R. 
Brown. J Ethnopharmacol. 2009;126(2):355–60.
 10. Qu X‑J, Xia X, Wang Y‑S, Song M‑J, Liu L‑L, Xie Y‑Y, et al. Protective effects 
of Salvia plebeia compound homoplantaginin on hepatocyte injury. Food 
Chem Toxicol. 2009;47(7):1710–5.
 11. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of 
chemokine receptor expression on human polarized T helper 1 and 2 
lymphocytes. J Exp Med. 1998;187(6):875–83.
 12. Whelan R, Kim C, Chen M, Leiter J, Grunstein MM, Hakonarson H. Role and 
regulation of interleukin‑1 molecules in pro‑asthmatic sensitised airway 
smooth muscle. Eur Respir J. 2004;24:559–67.
 13. Jiao A, Fish SC, Mason LE, Schelling SH, Goldman SJ, Williams CM. A role 
for endothelial selectins in allergic and nonallergic inflammatory disease. 
Ann Allergy Asthma Immunol. 2007;98(1):83–8.
 14. Verspohl EJ, Podlogar J. LPS‑induced proliferation and chemokine secre‑
tion from BEAS‑2B cells. Pharmacol Pharm. 2012;3:166–77.
 15. Chiu P‑R, Lee W‑T, Chu Y‑T, Lee M‑S, Jong Y‑J, Hung C‑H. Effect of the Chi‑
nese herb extract osthol on IL‑4‑induced eotaxin expression in BEAS‑2B 
cells. Pediatr Neonatol. 2008;49(4):135–40.
 16. Saetta M, Turato G. Airway pathology in asthma. Eur Respir Jl. 2001;18(34 
suppl):18s–23s.
 17. Lemière C, Ernst P, Olivenstein R, Yamauchi Y, Govindaraju K, Ludwig MS, 
et al. Airway inflammation assessed by invasive and noninvasive means 










17    18     19     20     21    22     23 
( 20 µg OVA +2mg Alum )/200µl PBS i.p
Fig. 8 Mouse model of allergic asthma. Mice were sensitized with an intraperitoneal (i.p.) injection of 20 µg of ovalbumin (OVA) emulsified in 2 mg 
aluminium hydroxide in a total volume of 200 µL in phosphate‑buffered saline (PBS) per animal on days 0 and 14. The challenge was administered 
by inhalation of nebulized 3 % OVA for 30 min on days 21, 22, and 23. Oral treatment, consisting of 3 mg/kg of dexamethasone or 100 mg/kg of 
SE‑A, was administered from day 17 to day 23 of the protocol
Page 11 of 11Jang et al. Biol Res  (2016) 49:41 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 18. Carroll N, Cooke C, James A. The distribution of eosinophils and 
lymphocytes in the large and small airways of asthmatics. Eur Respir J. 
1997;10(2):292–300.
 19. Saeed W, Badar A, Hussain MM, Aslam M. Eosinophils and eosinophil 
products in asthma. J Ayub Med Coll Abbottabad. 2002;14(4):49–55.
 20. Lee M‑Y, Ahn K‑S, Lim H‑S, Yuk J‑E, Kwon O‑K, Lee K‑Y, et al. Tiarellic acid 
attenuates airway hyperresponsiveness and inflammation in a murine 
model of allergic asthma. Int Immunopharmacol. 2012;12(1):117–24.
 21. Chung K, Barnes P. Cytokines in asthma. Thorax. 1999;54(9):825–57.
 22. Wills‑Karp M. Interleukin‑13: central Mediator of Allergic Asthma. 
Science (New York, NY). 1998;282(5397):2258–61. doi:10.1126/
science.282.5397.2258.
 23. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 defi‑
ciency abolishes eosinophilia, airways hyperreactivity, and lung damage 
in a mouse asthma model. J Exp Med. 1996;183(1):195–201.
 24. Quan Z, Lee YJ, Yang JH, Lu Y, Li Y, Lee YK, et al. Ethanol extracts of Sauru-
rus chinensis suppress ovalbumin‑sensitization airway inflammation. J 
Ethnopharmacol. 2010;132(1):143–9. doi:10.1016/j.jep.2010.08.002.
 25. Jin XF, Lu YH, Wei DZ, Wang ZT. Chemical fingerprint and quantitative 
analysis of Salvia plebeia R. Br. by high‑performance liquid chromatogra‑
phy. J Pharm Biomed Anal. 2008;48(1):100–4.
 26. Jin M, Yang JH, Lee E, Lu Y, Kwon S, Son KH, Son JK, Chang HW. Antiasth‑
matic activity of luteolin‑7‑O‑glucoside from Ailanthus altissima through 
the downregulation of T helper 2 cytokine expression and inhibition of 
prostaglandin E2 production in an ovalbumin‑induced asthma model. 
Biol Pharm Bull. 2009;32(9):1500–3.
 27. Ren DB, Qin YH, Yun YH, Lu HM, Chen XQ, Liang YZ. Separation of 
nine compounds from Salvia plebeia R.Br. using two‑step high‑speed 
counter‑current chromatography with different elution modes. J Sep Sci. 
2014;37(16):2118–25.
 28. He B, Zhang B, Wu F, Wang L, Shi X, Qin W, Lin Y, Ma S, Liang J. Homoplan‑
taginin inhibits palmitic acid‑induced endothelial cells inflammation by 
suppressing TLR4 and NLRP3 inflammasome. J Cardiovasc Pharmacol. 
2016;67(1):93–101.
 29. Boeor S, Silvestri M, Ullman N, Rossi GA. TNF‑alpha modulation by 
flunisolide of tumor necrosis factor‑α–induced stimulation of airway 
epithelial cell activities related to eosinophil Inflammation. J Asthma. 
2010;47(4):381–7.
